市販薬の市場規模、シェア、成長分析：製品タイプ別、エンドユーザー別、流通チャネル別、地域別 - 産業予測 2025年～2032年

市販薬2023年の市場規模は590億米ドルで、2024年の614億8,000万米ドルから2032年には854億4,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは4.2％で成長する見通しです。

一般用医薬品（OTC）市場は顕著な成長を遂げているが、その主な要因は、消費者が軽度の疾病に対して費用対効果の高い解決策を求めるようになり、セルフメディケーションの傾向が強まっていることです。この変化の背景には、ヘルスケアコストの上昇と多忙なライフスタイルがあり、アレルギー、鎮痛、消化器系疾患などの症状に対してOTC治療薬を選択する消費者が増えています。加えて、世界の高齢化も需要を高めています。高齢者は関節炎や高血圧などの慢性疾患の管理にOTCを利用することが多いからです。eコマースとデジタルプラットフォームの進歩は、消費者のアクセス性と利便性をさらに高めています。しかし、市場は厳しい規制や誤用の可能性などの課題に直面しています。こうした懸念に対処し、OTC医薬品の安全な使用を確保するためには、責任あるセルフメディケーションの実践について消費者を教育することが不可欠です。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

市販薬市場規模：製品タイプ別& CAGR（2025-2032）

• 市場概要
• 鎮痛剤
• 風邪咳インフルエンザ対策製品
• 胃腸薬
• 眼科用製品
• 皮膚科製品
• その他

市販薬市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 専門クリニック
• ホームケア
• 病院
• その他

市販薬市場規模：流通チャネル別& CAGR（2025-2032）

• 市場概要
• 病院薬局
• 小売薬局
• オンライン薬局
• その他

市販薬市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Johnson & Johnson（United States）
• Pfizer（United States）
• GlaxoSmithKline（United Kingdom）
• Sanofi（France）
• Bayer（Germany）
• Novartis（Switzerland）
• Merck & Co.（United States）
• Abbott Laboratories（United States）
• Amgen（United States）
• Bristol-Myers Squibb（United States）
• Eli Lilly and Company（United States）
• AstraZeneca（United Kingdom）
• Roche（Switzerland）
• AbbVie（United States）
• Gilead Sciences（United States）
• Biogen（United States）
• Regeneron Pharmaceuticals（United States）
• Vertex Pharmaceuticals（United States）
• Takeda Pharmaceutical（Japan）
• Daiichi Sankyo（Japan）

結論と推奨事項

Over The Counter Drugs Market size was valued at USD 59.0 billion in 2023 and is poised to grow from USD 61.48 billion in 2024 to USD 85.44 billion by 2032, growing at a CAGR of 4.2% during the forecast period (2025-2032).

The over-the-counter (OTC) drugs market is experiencing notable growth, largely fueled by the trend towards self-medication as consumers seek cost-effective solutions for minor ailments. This shift is driven by rising healthcare costs and hectic lifestyles, prompting individuals to choose OTC treatments for conditions like allergies, pain relief, and digestive issues. Additionally, the aging global population is increasing demand, as elderly individuals often rely on OTC options for managing chronic conditions such as arthritis and hypertension. Advancements in e-commerce and digital platforms further enhance accessibility and convenience for consumers. However, the market faces challenges, including stringent regulations and the potential for misuse. Educating consumers on responsible self-medication practices is essential to address these concerns and ensure safe usage of OTC drugs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Over The Counter Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Over The Counter Drugs Market Segments Analysis

Global Over The Counter Drugs Market is segmented by Product type, End-Users, Distribution Channel and Region. Based on Product type, the market is segmented into Analgesics, Cold, Cough and Flu products, Gastrointestinal Products, Ophthalmic Product, Dermatology Products and Others. Based on End-Users, the market is segmented into Speciality Clinic, Homecare, Hospital and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Over The Counter Drugs Market

The rising costs of healthcare and the growing financial pressure on individuals significantly boost the demand for affordable alternatives. Over-the-counter (OTC) drugs present a more budget-friendly option compared to prescription medications, appealing to consumers who are looking for economical solutions for self-medication. As people seek ways to manage their health without incurring high expenses, the attractiveness of OTC drugs as a cost-effective choice becomes increasingly pronounced. This trend reflects a larger movement towards personal health management, where consumers prioritize accessible and financial viable products to address their healthcare needs.

Restraints in the Over The Counter Drugs Market

The Over-the-Counter (OTC) drugs market faces significant constraints due to its inherent focus on self-treatment for common ailments and minor health issues. Many medical conditions, especially those that are more serious, necessitate prescription medications and expert medical advice, which limits the range of health concerns that OTC products can address. This restriction on treatment options can hinder the growth potential of the OTC drugs market, as consumers may require alternatives that are not available over-the-counter. Consequently, the reliance on professional healthcare guidance for more severe health issues poses a barrier to the expansion of this market segment.

Market Trends of the Over The Counter Drugs Market

The Over The Counter (OTC) Drugs market is experiencing significant growth, driven by an increasing emphasis on self-care and preventive healthcare among consumers. As individuals become more health-conscious and proactive in managing minor ailments, the demand for OTC products is rising. This trend is further fueled by escalating healthcare costs and a growing preference for convenience and accessibility in healthcare solutions. The shift towards self-treatment empowers consumers to take charge of their well-being, leading to a broader acceptance of OTC pharmaceuticals. As a result, the market is projected to expand, with innovative product offerings catering to this evolving consumer behavior.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Over The Counter Drugs Market Size by Product type & CAGR (2025-2032)

• Market Overview
• Analgesics
• Cold, Cough and Flu products
• Gastrointestinal Products
• Ophthalmic Product
• Dermatology Products
• Others

Global Over The Counter Drugs Market Size by End-Users & CAGR (2025-2032)

• Market Overview
• Speciality Clinic
• Homecare
• Hospital
• Others

Global Over The Counter Drugs Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Global Over The Counter Drugs Market Size & CAGR (2025-2032)

• North America (Product type, End-Users, Distribution Channel)
  • US
  • Canada
• Europe (Product type, End-Users, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product type, End-Users, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product type, End-Users, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product type, End-Users, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogen (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regeneron Pharmaceuticals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vertex Pharmaceuticals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daiichi Sankyo (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations